A library of peptide research, organized by hub.
Five subject hubs: peptide science fundamentals, analytical quality, evidence standards, compound profiles by pathway, and regulatory science. Every article separates molecule-level evidence from product-level status.
Discovery & Development
Drug discovery, AI-driven design, manufacturing, and the path from molecule to candidate.
AI-Designed Peptides and the New Research Bottleneck: Validation, Testing, and Reproducibility
AI can generate peptide candidates faster than traditional discovery workflows, but speed creates a new bottleneck: validation. This article explains why identity confirmation, purity testing, biological assays, reproducibility, and evidence mapping become even more important as AI expands the candidate pipeline.
Read articleFrom Literature Review to Candidate Selection: How LLMs Are Changing Biomedical Research
Large language models are changing the front end of biomedical research. By organizing literature, extracting patterns, and supporting hypothesis generation, LLMs may help researchers move from scattered evidence to testable candidate lists faster than traditional workflows.
Read articleAI in Peptide Research: How LLMs and Generative Models Are Accelerating Discovery
Artificial intelligence is changing how researchers identify targets, design peptide sequences, and prioritize experiments. This article examines where AI is already accelerating peptide research, where the technology remains limited, and why experimental validation still determines scientific value.
Read articleGreen Chemistry and the Future of Peptide Manufacturing
Peptide synthesis can consume large volumes of solvents and reagents. Green chemistry seeks to reduce that burden without compromising identity or quality.
Read articlePeptide Manufacturing: From Solid-Phase Synthesis to Purification
Peptide manufacturing is a sequence of chemical reactions and separations. Every stage can create impurities that must be understood and controlled.
Read articleWhy Cyclization Can Improve Peptide Drug Properties
Cyclization constrains peptide structure and can improve stability or affinity, but the outcome depends on ring size, linkage, sequence, and target.
Read articlePeptide-Drug Conjugates: A Growing Research Frontier
Peptide-drug conjugates use a peptide as a targeting, transport, or biological component linked to a separate payload. Their performance depends on the entire construct.
Read articleLong-Acting Peptide Formulations: How Researchers Extend Exposure
Long-acting peptide design uses chemistry and formulation to slow degradation or clearance, but each strategy creates a distinct molecular and analytical profile.
Read articleThe Science of Oral Peptide Delivery
An oral dosage form does not prove oral bioavailability. Peptides must survive the gastrointestinal environment and cross several biological barriers.
Read articleWhy Peptide Delivery Remains a Major Scientific Challenge
Peptides can be potent and selective, yet delivery often determines whether that pharmacology can be translated into useful exposure.
Read articleFrom Lead Peptide to Clinical Candidate
A peptide becomes a clinical candidate only after chemistry, pharmacology, manufacturing, and safety evidence converge around a defined material.
Read articleAI-Driven Peptide Design: Promise, Limits, and Validation
AI can search peptide sequence space faster than conventional methods, but prediction quality depends on data quality, model assumptions, and rigorous wet-lab validation.
Read articleHow Peptide Drugs Are Discovered
Peptide discovery is not a single technique. It is a sequence of hypothesis generation, screening, molecular optimization, analytical confirmation, and experimental validation.
Read article